Extended Data Fig. 5: Trough plasma obicetrapib levels. | Nature Medicine

Extended Data Fig. 5: Trough plasma obicetrapib levels.

From: Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial

Extended Data Fig. 5

Median (interquartile range) trough plasma obicetrapib levels in patients treated with obicetrapib at baseline, days 84, 180 and 365 and at 35 days following the last administration of study drug. Sample size: n = 236 (obicetrapib group only). Each data point represents median trough plasma concentration from biological replicates (individual patients) at specified timepoints.

Back to article page